These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1786560)

  • 1. Lack of saturable transport across the blood-brain barrier in either direction for beta-amyloid1-28 (Alzheimer's disease protein).
    Banks WA; Kastin AJ; Barrera CM; Maness LM
    Brain Res Bull; 1991 Dec; 27(6):819-23. PubMed ID: 1786560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential transport of a secretin analog across the blood-brain and blood-cerebrospinal fluid barriers of the mouse.
    Banks WA; Goulet M; Rusche JR; Niehoff ML; Boismenu R
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1062-9. PubMed ID: 12183664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permeability of the murine blood-brain barrier to some octapeptide analogs of somatostatin.
    Banks WA; Schally AV; Barrera CM; Fasold MB; Durham DA; Csernus VJ; Groot K; Kastin AJ
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6762-6. PubMed ID: 1975697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passage of human amyloid beta-protein 1-40 across the murine blood-brain barrier.
    Maness LM; Banks WA; Podlisny MB; Selkoe DJ; Kastin AJ
    Life Sci; 1994; 55(21):1643-50. PubMed ID: 7968239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aluminum-sensitive degradation of amyloid beta-protein 1-40 by murine and human intracellular enzymes.
    Banks WA; Maness LM; Banks MF; Kastin AJ
    Neurotoxicol Teratol; 1996; 18(6):671-7. PubMed ID: 8947944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to beta-amyloid decrease the blood-to-brain transfer of beta-amyloid peptide.
    Pan W; Solomon B; Maness LM; Kastin AJ
    Exp Biol Med (Maywood); 2002 Sep; 227(8):609-15. PubMed ID: 12192102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-borne interleukin-1 alpha is transported across the endothelial blood-spinal cord barrier of mice.
    Banks WA; Kastin AJ; Ehrensing CA
    J Physiol; 1994 Sep; 479 ( Pt 2)(Pt 2):257-64. PubMed ID: 7799225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsaturable entry of neuropeptide Y into brain.
    Kastin AJ; Akerstrom V
    Am J Physiol; 1999 Mar; 276(3):E479-82. PubMed ID: 10070013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passage of vasoactive intestinal peptide across the blood-brain barrier.
    Dogrukol-Ak D; Banks WA; Tuncel N; Tuncel M
    Peptides; 2003 Mar; 24(3):437-44. PubMed ID: 12732342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system.
    Bell RD; Sagare AP; Friedman AE; Bedi GS; Holtzman DM; Deane R; Zlokovic BV
    J Cereb Blood Flow Metab; 2007 May; 27(5):909-18. PubMed ID: 17077814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions.
    Mackic JB; Bading J; Ghiso J; Walker L; Wisniewski T; Frangione B; Zlokovic BV
    Vascul Pharmacol; 2002 Jun; 38(6):303-13. PubMed ID: 12529925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agouti-related protein(83-132) aggregates and crosses the blood-brain barrier slowly.
    Kastin AJ; Akerstrom V; Hackler L
    Metabolism; 2000 Nov; 49(11):1444-8. PubMed ID: 11092509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-2 does not cross the blood-brain barrier by a saturable transport system.
    Waguespack PJ; Banks WA; Kastin AJ
    Brain Res Bull; 1994; 34(2):103-9. PubMed ID: 8044683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor.
    Wu D; Yang J; Pardridge WM
    J Clin Invest; 1997 Oct; 100(7):1804-12. PubMed ID: 9312181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of blood-brain barrier permeability to PYY3-36 in the mouse.
    Nonaka N; Shioda S; Niehoff ML; Banks WA
    J Pharmacol Exp Ther; 2003 Sep; 306(3):948-53. PubMed ID: 12750431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional variations in the transport of interleukin-1alpha across the blood-brain barrier in ICR and aging SAMP8 mice.
    Moinuddin A; Morley JE; Banks WA
    Neuroimmunomodulation; 2000; 8(4):165-70. PubMed ID: 11251390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex.
    Saito Y; Buciak J; Yang J; Pardridge WM
    Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10227-31. PubMed ID: 7479757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse.
    Gutierrez EG; Banks WA; Kastin AJ
    J Neuroimmunol; 1993 Sep; 47(2):169-76. PubMed ID: 8370768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of multiple-time regression analysis in measurement of tritiated and iodinated leptin crossing the blood-brain barrier: meaningful controls.
    Kastin AJ; Akerstrom V; Pan W
    Peptides; 2001 Dec; 22(12):2127-36. PubMed ID: 11786200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairments in brain-to-blood transport of amyloid-β and reabsorption of cerebrospinal fluid in an animal model of Alzheimer's disease are reversed by antisense directed against amyloid-β protein precursor.
    Banks WA; Kumar VB; Farr SA; Nakaoke R; Robinson SM; Morley JE
    J Alzheimers Dis; 2011; 23(4):599-605. PubMed ID: 21098986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.